New delivery systems may revive potential of peptide drugs

01/14/2005 | InPharm.com

New therapeutic approaches, plus the potential of the drugs themselves, may mean a renaissance in peptide drugs, according to a new report. Approval of new peptide-based drug products, such as Roche's HIV treatment Fuzeon, is increasing interest among pharmaceutical companies. In Europe, as many as six peptide-based products are on the market, with 100 in the clinical stage and 150 in advanced preclinical phases.

View Full Article in:

InPharm.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC